The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Role of Altered Renal Lipid Metabolism in the Development of Renal Injury Induced by a High-Fat Diet
Open accessAbstract
Metabolic syndrome is associated with increased risk of chronic kidney disease, and the renal injury in patients with metabolic syndrome may be a result of altered renal lipid metabolism. We fed wild-type or insulin-sensitive heterozygous peroxisome proliferator-activated receptor gamma-deficient (PPARgamma(+/-)) mice a high-fat diet for 16 weeks. In wild-type mice, this diet induced core features of metabolic syndrome, subsequent renal lipid accumulation, and renal injury including glomerulosclerosis, interstitial fibrosis, and albuminuria. Renal lipogenesis accelerated, determined by increased renal mRNA expression of the lipogenic enzymes fatty acid synthase and acetyl-CoA carboxylase (ACC) and by increased ACC activity. In addition, renal lipolysis was suppressed, determined by reduced mRNA expression of the lipolytic enzyme carnitine palmitoyl acyl-CoA transferase 1 and by reduced activity of AMP-activated protein kinase. In PPARgamma(+/-) mice, renal injury, systemic metabolic abnormalities, renal accumulation of lipids, and the changes in renal lipid metabolism were attenuated. Thus, a high-fat diet leads to an altered balance between renal lipogenesis and lipolysis, subsequent renal accumulation of lipid, and renal injury. We suggest that renal lipid metabolism could serve as a new therapeutic target to prevent chronic kidney disease in patients with metabolic syndrome.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A RAPID METHOD OF TOTAL LIPID EXTRACTION AND PURIFICATION
Bligh, E. G., & Dyer, W. J. (1959) · Canadian Journal of Biochemistry and Physiology · doi:10.1139/o59-099 · Cited by 54,751
The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men
Lakka, H.-M. (2002) · JAMA · doi:10.1001/jama.288.21.2709 · Cited by 5,033
SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver
Horton, J. D., Goldstein, J. L., & Brown, M. S. (2002) · Journal of Clinical Investigation · doi:10.1172/jci15593 · Cited by 4,794
Cardiovascular Morbidity and Mortality Associated With the Metabolic Syndrome
Isomaa, B., Almgren, P., Tuomi, T., Forsén, B., Lahti, K., Nissén, M., Taskinen, M.-R., & Groop, L. (2001) · Diabetes Care · doi:10.2337/diacare.24.4.683 · Cited by 4,760
The Metabolic Syndrome and Chronic Kidney Disease in U.S. Adults
Chen, J., Muntner, P., Hamm, L. L., Jones, D. W., Batuman, V., Fonseca, V., Whelton, P. K., & He, J. (2004) · Annals of Internal Medicine · doi:10.7326/0003-4819-140-3-200402030-00007 · Cited by 1,359
PPARγ Mediates High-Fat Diet–Induced Adipocyte Hypertrophy and Insulin Resistance
Kubota, N., Terauchi, Y., Miki, H., Tamemoto, H., Yamauchi, T., Komeda, K., Satoh, S., Nakano, R., Ishii, C., Sugiyama, T., et al. (1999) · Molecular Cell · doi:10.1016/s1097-2765(00)80210-5 · Cited by 1,342
Self-citationSkeletal muscle triglyceride levels are inversely related to insulin action
Pan, D. A., Lillioja, S., Kriketos, A. D., Milner, M. R., Baur, L. A., Bogardus, C., Jenkins, A. B., & Storlien, L. H. (1997) · Diabetes · doi:10.2337/diabetes.46.6.983 · Cited by 1,179
Skeletal Muscle Triglyceride Levels Are Inversely Related to Insulin Action
Pan, D. A., Lillioja, S., Kriketos, A. D., Milner, M. R., Baur, L. A., Bogardus, C., Jenkins, A. B., & Storlien, L. H. (1997) · Diabetes · doi:10.2337/diab.46.6.983 · Cited by 1,179
AMP-activated protein kinase signaling in metabolic regulation
Long, Y. C. (2006) · Journal of Clinical Investigation · doi:10.1172/jci29044 · Cited by 1,098
Sorting out the roles of PPAR in energy metabolism and vascular homeostasis
Lefebvre, P. (2006) · Journal of Clinical Investigation · doi:10.1172/jci27989 · Cited by 962
Wisse, B. E. (2004) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000141966.69934.21 · Cited by 933
Lipid Metabolism and Liver Inflammation. II. Fatty liver disease and fatty acid oxidation
Reddy, J. K., & Sambasiva Rao, M. (2006) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00521.2005 · Cited by 860
Yamauchi, T., Kamon, J., Waki, H., Murakami, K., Motojima, K., Komeda, K., Ide, T., Kubota, N., Terauchi, Y., Tobe, K., et al. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m103241200 · Cited by 637
Self-citationMatsusue, K., Haluzik, M., Lambert, G., Yim, S.-H., Gavrilova, O., Ward, J. M., Brewer, B., Reitman, M. L., & Gonzalez, F. J. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200317223 · Cited by 585
Impaired free fatty acid utilization by skeletal muscle in non-insulin-dependent diabetes mellitus.
Kelley, D. E., & Simoneau, J. A. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117600 · Cited by 487
Jones, J. R., Barrick, C., Kim, K.-A., Lindner, J., Blondeau, B., Fujimoto, Y., Shiota, M., Kesterson, R. A., Kahn, B. B., & Magnuson, M. A. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0306743102 · Cited by 486
Fatty Acid Regulation of Hepatic Gene Transcription
Jump, D. B., Botolin, D., Wang, Y., Xu, J., Christian, B., & Demeure, O. (2005) · The Journal of Nutrition · doi:10.1093/jn/135.11.2503 · Cited by 477
KOYA, D., HANEDA, M., NAKAGAWA, H., ISSHIKI, K., SATO, H., MAEDA, S., SUGIMOTO, T., YASUDA, H., KASHIWAGI, A., WAYS, D. K., et al. (2000) · The FASEB Journal · doi:10.1096/fasebj.14.3.439 · Cited by 427
Self-citationJiang, T., Wang, Z., Proctor, G., Moskowitz, S., Liebman, S. E., Rogers, T., Lucia, M. S., Li, J., & Levi, M. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m500801200 · Cited by 387
Sun, L., Halaihel, N., Zhang, W., Rogers, T., & Levi, M. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m110650200 · Cited by 333
The SREBP pathway — insights from insigs and insects
Rawson, R. B. (2003) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1174 · Cited by 323
Wang, Z., Jiang, T., Li, J., Proctor, G., McManaman, J. L., Lucia, S., Chua, S., & Levi, M. (2005) · Diabetes · doi:10.2337/diabetes.54.8.2328 · Cited by 303
Obesity-Initiated Metabolic Syndrome and the Kidney: A Recipe for Chronic Kidney Disease?
Bagby, S. P. (2004) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000141965.28037.ee · Cited by 257
Regulation of Fat Metabolism in Skeletal Muscle
JEUKENDRUP, A. E. (2002) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2002.tb04278.x · Cited by 253
Yu, C., Markan, K., Temple, K. A., Deplewski, D., Brady, M. J., & Cohen, R. N. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m409468200 · Cited by 238
Protection of the kidney by thiazolidinediones: An assessment from bench to bedside
Sarafidis, P. A., & Bakris, G. L. (2006) · Kidney International · doi:10.1038/sj.ki.5001620 · Cited by 222
The Relationship between Hyperinsulinemia, Hypertension and Progressive Renal Disease
El-Atat, F. A., Stas, S. N., McFarlane, S. I., & Sowers, J. R. (2004) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000133698.80390.37 · Cited by 202
Isshiki, K., Haneda, M., Koya, D., et al. (2000) · Diabetes · doi:10.2337/diabetes.49.6.1022 · Cited by 184
Self-citationObesity--a neglected culprit in renal disease
Praga, M. (2002) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/17.7.1157 · Cited by 136
Jiang, T., Liebman, S. E., Lucia, M. S., Li, J., & Levi, M. (2005) · Kidney International · doi:10.1111/j.1523-1755.2005.00733.x · Cited by 123
Guo, B., Koya, D., Isono, M., Sugimoto, T., Kashiwagi, A., & Haneda, M. (2004) · Diabetes · doi:10.2337/diabetes.53.1.200 · Cited by 123
Self-citationBonnet, F., & Cooper, M. E. (2000) · PubMed · Cited by 106
Wei, P., Lane, P. H., Lane, J. T., Padanilam, B. J., & Sansom, S. C. (2004) · Diabetologia · doi:10.1007/s00125-004-1489-1 · Cited by 90
Abrass, C. K. (2004) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000141963.04540.3e · Cited by 82
陳, 雅., Isono, M., Isshiki, K., et al. (2005) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)62473-x · Cited by 78
Self-citationSpencer, M. W., Mühlfeld, A., Segerer, S., Hudkins, K. L., Kirk, E. A., LeBoeuf, R. C., & Alpers, C. E. (2003) · American Journal of Nephrology · doi:10.1159/000075362 · Cited by 52
Nuclear Receptor Corepressors and PPARγ
Cohen, R. (2006) · Nuclear Receptor Signaling · doi:10.1621/nrs.04003 · Cited by 39
Lipids, protein intake, and diabetic nephropathy.
Gin, H., Rigalleau, V., & Aparicio, M. (2000) · PubMed · Cited by 38
Cited by
Obesity-related glomerulopathy: clinical and pathologic characteristics and pathogenesis
D'Agati, V. D., Chagnac, A., de Vries, A. P. J., Levi, M., Porrini, E., Herman-Edelstein, M., & Praga, M. (2016) · Nature Reviews Nephrology · doi:10.1038/nrneph.2016.75 · Cited by 716
Kume, S., Uzu, T., Horiike, K., Chin-Kanasaki, M., Isshiki, K., Araki, S.-I., Sugimoto, T., Haneda, M., Kashiwagi, A., & Koya, D. (2010) · Journal of Clinical Investigation · doi:10.1172/jci41376 · Cited by 640
Self-citationMechanisms of obesity-induced hypertension
Kotsis, V., Stabouli, S., Papakatsika, S., Rizos, Z., & Parati, G. (2010) · Hypertension Research · doi:10.1038/hr.2010.9 · Cited by 627
Noeman, S. A., Hamooda, H. E., & Baalash, A. A. (2011) · Diabetology & Metabolic Syndrome · doi:10.1186/1758-5996-3-17 · Cited by 518
Lipid metabolism in sickness and in health: Emerging regulators of lipotoxicity
Yoon, H., Shaw, J. L., Haigis, M. C., & Greka, A. (2021) · Molecular Cell · doi:10.1016/j.molcel.2021.08.027 · Cited by 510
Metadata
- Authors
- Kume, S., Uzu, T., Araki, S.-I., Sugimoto, T., Isshiki, K., Chin-Kanasaki, M., Sakaguchi, M., Kubota, N., Terauchi, Y., Kadowaki, T., Haneda, M., Kashiwagi, A., & Koya, D.
- Venue
- Journal of the American Society of Nephrology
- Published
- 2007-10
- Volume
- 18
- Issue
- 10
- Pages
- 2715-2723
- ISSN
- 1046-6673 (ISSN-L)
- OpenAlex
- W2155155293
- Cited by
- 278
- References
- 38
- FWCI
- 3.35
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.